CATALYST PHARMACEUTICALS, INC. — Director's Dealing 2023

May 17, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2023-05-15

Reporting Person: MCENANY PATRICK J (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-05-15	Common stock, par value $0.001 per share	M	26151	$0.79	Acquired	3971587	Direct
2023-05-15	Common stock, par value $0.001 per share	S	26151	$13.23	Disposed	3945436	Direct
2023-05-16	Common stock, par value $0.001 per share	M	173849	$0.79	Acquired	4119285	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-05-15	Options to purchase common stock	$0.79	M	26151	Disposed	2023-06-15	Common Stock (26151)	Direct
2023-05-16	Options to purchase common stock	$0.79	M	173849	Disposed	2023-06-15	Common Stock (173849)	Direct

Footnotes

F1: Shares were sold to cover tax withholding requirements.

F2: Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $13.20 to $13.285 per share.

F3: Options vested in two equal tranches beginning on June 15, 2017.